Lantern Pharma Inc. — Form D
Lantern Pharma Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-14. The offering totals $535K, of which $535K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-01-14
- Form: D
- Accession: 0001763950-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $535K
- Amount sold: $535K
- Investors: 5
- Date of first sale: 2018-12-18
- Revenue range: Decline to Disclose
- SEC file number: 021-330392
Issuer
- Name: Lantern Pharma Inc.
- CIK: 0001763950
- Entity type: Corporation
- Jurisdiction: TEXAS
- Address: 1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS, TX, 75201
- Phone: (972) 277-1136
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| David Keyser | Director | Dallas, TX |
| Donald Keyser | Director | Encinitas, CA |
| John Fucci | Director | El Cajon, CA |
| Maria Maccecchini | Related Person | Dallas, TX |
| David Silberstein | Director | Dallas, TX |
| Arunkumar Asaithambi | Director | Dallas, TX |
| Panna Sharma | Director | Dallas, TX |
| Panna Sharma | Executive Officer | Dallas, TX |
| Panna Sharma | Related Person | Dallas, TX |
| Donald Jeffrey Keyser | Related Person | Fort Worth, TX |
| David R. Margrave | Related Person | Dallas, TX |
| Kishor G. Bhatia | Related Person | Dallas, TX |
| Vijay Chandru | Related Person | Dallas, TX |
| Lee T. Schalop | Related Person | Dallas, TX |
| David S. Silberstein | Related Person | Dallas, TX |
Other filings by this issuer (2)
More